ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

November 29, 2002

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980